SCHEMBL31153493

SCHEMBL31153493

CCOC(=O)C(=O)Nc1cc(Br)cnc1C=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 5/20 0.57
▸ ALDH1A1 P00352 4/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ KMT2A Q03164 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ CYP19A1 P11511 1/20 0.39
▸ AKR1B1 P15121 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MYC P01106 1/20 0.38
▸ MAX P61244 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31153437 0.94 GPR35 (0.54) GPR35ALDH1A1NPC1RAB9APKM
SCHEMBL28871079 0.78 RAB9A (0.44) ALDH1A1NPC1RAB9APKMKMT2A
SCHEMBL29967324 0.78 RAB9A (0.44) ALDH1A1NPC1RAB9APKMKMT2A
SCHEMBL24150497 0.76 GPR35 (0.59) GPR35ALDH1A1NPC1RAB9AKMT2A
SCHEMBL29603602 0.75 OPRK1 (0.46) ALDH1A1NPC1RAB9AKMT2AGAA
SCHEMBL14054179 0.75 OPRK1 (0.46) ALDH1A1NPC1RAB9AKMT2AGAA
SCHEMBL21865492 0.75 GPR35 (0.58) GPR35ALDH1A1NPC1RAB9AKMT2A
SCHEMBL31153450 0.74 GPR35 (0.60) GPR35ALDH1A1NPC1RAB9APKM
SCHEMBL27251873 0.72 GPR35 (0.62) GPR35ALDH1A1NPC1RAB9APKM
SCHEMBL31153439 0.71 GPR35 (0.56) GPR35ALDH1A1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698544-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-02-25 — — EP disclosed
WO-2024220946-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 — — WO disclosed
Send feedback